HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 80 filers reported holding HOMOLOGY MEDICINES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $77,000 | -19.8% | 25,429 | -3.3% | 0.00% | – |
| Q4 2021 | $96,000 | -51.0% | 26,303 | +5.0% | 0.00% | – |
| Q3 2021 | $196,000 | +21.7% | 25,053 | +12.3% | 0.00% | – |
| Q2 2021 | $161,000 | +15.8% | 22,307 | +51.3% | 0.00% | – |
| Q1 2021 | $139,000 | -50.5% | 14,742 | -40.8% | 0.00% | – |
| Q4 2020 | $281,000 | +83.7% | 24,896 | +72.9% | 0.00% | – |
| Q3 2020 | $153,000 | -79.7% | 14,396 | -70.9% | 0.00% | -100.0% |
| Q2 2020 | $752,000 | +375.9% | 49,534 | +387.2% | 0.00% | – |
| Q1 2020 | $158,000 | -27.9% | 10,168 | -3.9% | 0.00% | – |
| Q4 2019 | $219,000 | -92.1% | 10,577 | -93.1% | 0.00% | -100.0% |
| Q3 2019 | $2,776,000 | +686.4% | 153,394 | +749.2% | 0.00% | – |
| Q2 2019 | $353,000 | -45.5% | 18,063 | -22.7% | 0.00% | -100.0% |
| Q1 2019 | $648,000 | +81.0% | 23,370 | +45.8% | 0.00% | – |
| Q4 2018 | $358,000 | – | 16,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 5,535,919 | $86,028,000 | 26.64% |
| VV Manager LLC | 770,845 | $11,979,000 | 13.54% |
| RTW INVESTMENTS, LP | 4,399,250 | $68,364,000 | 2.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,037,305 | $62,740,000 | 1.99% |
| COWEN AND COMPANY, LLC | 476,488 | $7,405,000 | 1.70% |
| Vivo Capital, LLC | 1,008,562 | $15,673,000 | 1.42% |
| Ghost Tree Capital, LLC | 200,000 | $3,108,000 | 0.82% |
| Bellevue Group AG | 1,612,122 | $25,052,000 | 0.49% |
| Cormorant Asset Management, LP | 600,000 | $9,324,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 3,220,293 | $50,043,000 | 0.37% |